Cheung, W.Y.; Carbonell, C.; Navani, V.; Sangha, R.S.; Ewara, E.M.; Elia-Pacitti, J.; Iczkovitz, S.; Jarada, T.N.; Warkentin, M.T.
Real-World Treatment Patterns, Health Outcomes, and Healthcare Resource Use in Advanced Common EGFR-Positive Non-Small Cell Lung Cancer Patients Treated with Osimertinib in Alberta. Curr. Oncol. 2024, 31, 4382-4396.
https://doi.org/10.3390/curroncol31080327
AMA Style
Cheung WY, Carbonell C, Navani V, Sangha RS, Ewara EM, Elia-Pacitti J, Iczkovitz S, Jarada TN, Warkentin MT.
Real-World Treatment Patterns, Health Outcomes, and Healthcare Resource Use in Advanced Common EGFR-Positive Non-Small Cell Lung Cancer Patients Treated with Osimertinib in Alberta. Current Oncology. 2024; 31(8):4382-4396.
https://doi.org/10.3390/curroncol31080327
Chicago/Turabian Style
Cheung, Winson Y., Chantelle Carbonell, Vishal Navani, Randeep S. Sangha, Emmanuel M. Ewara, Julia Elia-Pacitti, Sandra Iczkovitz, Tamer N. Jarada, and Matthew T. Warkentin.
2024. "Real-World Treatment Patterns, Health Outcomes, and Healthcare Resource Use in Advanced Common EGFR-Positive Non-Small Cell Lung Cancer Patients Treated with Osimertinib in Alberta" Current Oncology 31, no. 8: 4382-4396.
https://doi.org/10.3390/curroncol31080327
APA Style
Cheung, W. Y., Carbonell, C., Navani, V., Sangha, R. S., Ewara, E. M., Elia-Pacitti, J., Iczkovitz, S., Jarada, T. N., & Warkentin, M. T.
(2024). Real-World Treatment Patterns, Health Outcomes, and Healthcare Resource Use in Advanced Common EGFR-Positive Non-Small Cell Lung Cancer Patients Treated with Osimertinib in Alberta. Current Oncology, 31(8), 4382-4396.
https://doi.org/10.3390/curroncol31080327
